摘要
目的:探讨依达拉奉注射液治疗急性脑梗死的临床疗效。方法:收治51例急性脑梗死患者,随机分为对照组和治疗组。对照组给予常规治疗,治疗组在常规治疗基础上加用依达拉奉注射液,分别评价治疗前后2组临床疗效。结果:治疗1个疗程后,治疗组临床疗效总有效率81.5%,恶化1例,对照组临床疗效总有效率74.8%,恶化2例。两组临床疗效总有效率比较,差异有统计学意义,P<0.05。结论:在急性脑梗发病的早期选用依达拉奉治疗可提高临床疗效,值得借鉴。
Objective：To discuss clinical effect for edaravone in treatment of acute cerebral infarction.Methods：Choosed 51 cases suffered acute cerebral infarction to divide into study group and controlled group with 25 cases in each other.All these two groups were treated with rutine therapy,while study group treated with edaravone injection 2 times one day.14 d was a course of treatment.Compared clinical effect of two groups after treatment.Results：There were no difference in clinical symptom,CT,MRI,nerve checking before treating,bur after 1 course the total effect rate was 81.5%,1 case relapsed,while total effect rate was 74.8%,2 cases relapsed.Conclusion：In acute cerebral infarction of the early use of edaravone in treatment can improve the clinical curative effect,help improve the quality of life in patients with cerebral infarction after,it is worth using for reference.
出处
《求医问药（下半月刊）》
2012年第5期434-435,共2页
Seek Medical and Ask The Medicine
